Prosecution Insights
Last updated: October 27, 2026

Barry A Chestnut, USPTO Patent Examiner

Listed by the USPTO as CHESTNUT, BARRY A

Tech Center 1600 • Art Units: 1648 1671 1672

This examiner grants 74% of resolved cases

Analysis

CHESTNUT, BARRY A works in tech center 1600 and art unit 1648, with 762 resolved cases. The allowance rate is 73.9%, and the median time to allowance is 992 days. The interview lift is 6.3%, indicating only a limited positive association with interviews in this record.

The companies represented are Zoetis LLC, Dyno Therapeutics Inc., and Trustees of Boston University. The leading firms are BANNER & WITCOFF, LTD., Biospark Intellectual Property Law, and BOZICEVIC, FIELD & FRANCIS LLP. Counsel should prioritize substantive claim strategy, while retaining interviews as a targeted option.

Written from this page's own data; every figure is computed from USPTO records and verified before publication.

Performance Statistics

73.9%
Allow Rate
+13.9% vs TC avg
791
Total Applications
+6.3%
Interview Lift
992
Avg Prosecution Days
Based on 762 resolved cases, 2023–2026

Rejection Statute Breakdown

4.6%
§101 Eligibility
20.4%
§102 Novelty
42.8%
§103 Obviousness
22.6%
§112 Clarity

Currently Pending Office Actions

App #TitleStatusAssignee
18721719 COMPOSITIONS AND METHODS FOR PREVENTION OF PISCINE MYOCARDITIS Non-Final OA Zoetis Services LLC
18364753 GLYCAN MODIFIED NUCLEIC ACIDS, METHODS OF PREPARATION, AND THERAPEUTIC USES Non-Final OA The Board of Trustees of the Leland Stanford Junior University
18701156 MRNA VACCINE DESIGN VIA THE ALTERATION OF CODON USAGE Non-Final OA The Cleveland Clinic Foundation
18480009 USE AND DETECTION METHOD OF FLAVIVIRUS PROTEIN MICROARRAY Non-Final OA NATIONAL CHENG KUNG UNIVERSITY
18827183 SELF-REPLICATING RNA AND USES THEREOF Non-Final OA TRUSTEES OF BOSTON UNIVERSITY
18794860 FELINE LEUKEMIA VIRUS VACCINE Non-Final OA INTERVET INC.
18793638 METHOD OF COMPACT PEPTIDE VACCINES USING RESIDUE OPTIMIZATION Non-Final OA Think Therapeutics, Inc.

Facing This Examiner?

IP Author analyzes examiner patterns and generates tailored response strategies with the highest chance of allowance.

Build Your Strategy

Who Appears Before This Examiner

Top companies before this examiner

Law firms appearing most often

Frequently Asked Questions

What is examiner Barry A Chestnut's allowance rate?

73.9% of resolved applications examined by Barry A Chestnut were allowed (762 resolved cases), compared with 49.6% across Art Unit 1648 over the last five years.

Does an interview help with examiner Barry A Chestnut?

This examiner's interview lift is +6.3 percentage points: the difference in allowance rate between resolved applications that had an examiner interview and those that did not.

How long does examiner Barry A Chestnut take to allow a patent?

Applications allowed by Barry A Chestnut took 992 days on average from filing to allowance.

Which art unit does examiner Barry A Chestnut work in?

Barry A Chestnut examines applications in Art Unit 1648 in Tech Center 1600 (Biotechnology & Pharmaceuticals).

Sign in with your work email

Enter your email to receive a magic link. No password needed.

Personal email addresses (Gmail, Yahoo, etc.) are not accepted.

Free tier: 3 strategy analyses per month